Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| MuRF1-IN-1 | C18H15N3O3 | 445222-91-3 | Details |
| MPDC | C7H9NO4 | 159262-32-5 | Details |
| Sodium etidronate；Didronel | C2H9NaO7P2 | 7414-83-7 | Details |
| N-(3-Hydroxytetradecanoyl)-DL-homoserine lactone；N-(3-oxodecanoyl)-homoserine lactone | C18H33NO4 | 172670-99-4 | Details |
| N-Methylbenzamide | C8H9NO | 613-93-4 | Details |
| N6-Ethyladenosine | C12H17N5O4 | 14357-08-5 | Details |
| Mogroside I E1 | C36H62O9 | 88901-39-7 | Details |
| Y1 receptor antagonist 1；H 409-22 isomer | C28H33N5O3 | 221697-09-2 | Details |
| MS645 | C48H54Cl2N10O2S2 | 2250091-96-2 | Details |
| APNEA | C18H22N6O4 | 89705-21-5 | Details |
| MT-7716 hydrochloride；W-212393 hydrochloride | C27H29ClN4O2 | 1215859-93-0 | Details |
| Mutated EGFR-IN-3 | C31H29FN4O2 | 2375107-27-8 | Details |
| N-Desethyl Sunitinib；SU-11662 | C20H23FN4O2 | 356068-97-8 | Details |
| Piperacillin sodium | C23H26N5NaO7S | 59703-84-3 | Details |
| Nicardipine hydrochloride | C26H30ClN3O6 | 54527-84-3 | Details |
| N-Caffeoyl O-methyltyramine | C18H19NO4 | 189307-47-9 | Details |
| Mutant IDH1-IN-4 | C25H34N4O3 | 1416270-18-2 | Details |
| MRGPRX1 agonist 1 | C23H21N3O4S | 2377379-39-8 | Details |
| MUT056399 | C15H13F2NO3 | 1269055-85-7 | Details |
| N-Desmethyltamoxifen | C25H27NO | 31750-48-8 | Details |
| Nadolol-d9；Nadolol D9;SQ-11725 D9 | C17H27NO4 | 94513-92-5 | Details |
| Mutant IDH1-IN-2 | C24H31F2N5O2 | 1429176-69-1 | Details |
| MRZ 2-514；8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one | C11H6BrN3O3 | 202808-11-5 | Details |
| N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea | C13H12ClN3O | 97627-24-2 | Details |
| MOZ-IN-2 | C17H13FN4O3S | 2055397-88-9 | Details |
| MSOP | C4H10NO6P | 66515-29-5 | Details |
| Ketorolac tromethamine salt；Ketorolac tris salt;Acular;Acular LS;Toradol | C19H24N2O6 | 74103-07-4 | Details |
| N-Desethyl amodiaquine | C18H18ClN3O | 79352-78-6 | Details |
| Morphothiadin | C21H22BrFN4O3S | 1092970-12-1 | Details |
| MM-589 TFA | 2097887-21-1 | Details |
| MYCi361 | C26H16ClF9N2O2 | 2289690-31-7 | Details |
| Modecainide；BMY 40327;MJ 14030 | C22H28N2O3 | 81329-71-7 | Details |
| Mocravimod hydrochloride；KRP-203 | C24H27Cl2NO3S | 509088-69-1 | Details |
| Naltrindole hydrochloride | C26H27ClN2O3 | 111469-81-9 | Details |
| N-0861 racemate | C13H17N5 | 121241-87-0 | Details |
| mTOR inhibitor-2 | C23H21N7O | 2219323-96-1 | Details |
| N-Boc-Val-Dil-Dap-Doe | C40H63N5O7S | 135383-62-9 | Details |
| Ribostamycin sulfate | C17H36N4O14S | 53797-35-6 | Details |
| MT-7716 free base；W-212393 | C27H28N4O2 | 610323-32-5 | Details |
| MRT-83 | C31H30N4O5 | 1263131-92-5 | Details |
| N-(3-Methoxybenzyl)Palmitamide | C24H41NO2 | 847361-96-0 | Details |
| N-Desethyl amodiaquine dihydrochloride | C18H20Cl3N3O | 79049-30-2 | Details |
| 9-Propenyladenine；Tenofovir Impurity 2;Mutagenic Impurity of Tenofovir Disoproxil | C8H9N5 | 1446486-33-4 | Details |
| N-deacetylated BMS-202 | C23H27N3O2 | 2310135-18-1 | Details |
| MRS1845 | C21H22N2O6 | 544478-19-5 | Details |
| Levosulpiride；S-(-)-Sulpiride;RV-12309 | C15H23N3O4S | 23672-07-3 | Details |
| MM-589 | C28H44N8O5 | 2097887-20-0 | Details |
| N6-Cyclohexyladenosine | C16H23N5O4 | 36396-99-3 | Details |
| N-type calcium channel blocker-1 | C31H47N3 | 241499-17-2 | Details |
| Monobehenin | C25H50O4 | 30233-64-8 | Details |
| Mycophenolic acid-d3；Mycophenolate D3;Mycophenolic acid D3 | C17H20O6 | 1185242-90-3 | Details |
| MSC2360844 | C26H27FN4O5S | 1305267-37-1 | Details |
| MRS-3777 hemioxalate | C19H21N5O5 | 1186195-57-2 | Details |
| mTOR inhibitor-3 | C25H30N8O2 | 1207358-59-5 | Details |
| N-Desmethyl-Apalutamide | C20H13F4N5O2S | 1332391-11-3 | Details |
| MSI-1436 lactate；Trodusquemine lactate;Aminosterol-1436 lactate | C40H78N4O8S | 1309370-86-2 | Details |
| Flunixin meglumine | C14H11F3N2O2.C7H17NO5 | 42461-84-7 | Details |
| mPGES1-IN-3 | C24H16ClF5N4O3 | 1469976-70-2 | Details |
| nAChR agonist 1 | C20H18ClNO3S2 | 1394371-75-5 | Details |
| N6-(4-Hydroxybenzyl)adenosine | C17H19N5O5 | 110505-75-4 | Details |
| Monascin | C21H26O5 | 21516-68-7 | Details |
| N-Desmethyl Clomipramine hydrochloride；Desmethylclomipramine hydrochloride | C18H22Cl2N2 | 29854-14-6 | Details |
| Mps1-IN-1 | C28H33N5O4S | 1125593-20-5 | Details |
| MSI-1436；Aminosterol-1436;Trodusquemine | C37H72N4O5S | 186139-09-3 | Details |
| MRK-016 | C17H20N8O2 | 342652-67-9 | Details |
| N6-Methyladenosine 5'-monophosphate disodium salt | C11H14N5Na2O7P | 81921-35-9 | Details |
| N-(2-Hydroxypropyl)methacrylamide | C7H13NO2 | 21442-01-3 | Details |
| N6-(2-Phenylethyl)adenosine | C18H21N5O4 | 20125-39-7 | Details |
| MSC1094308 | C29H29F3N2 | 2219320-08-6 | Details |
| Nampt-IN-5 | C25H25N5O2 | 2380013-17-0 | Details |
| N-Desmethyltamoxifen hydrochloride | C25H27NO.ClH | 15917-65-4 | Details |
| Mogroside I A1 | C36H62O9 | 88901-46-6 | Details |
| Nacubactam | C9H16N4O7S | 1452458-86-4 | Details |
| MT-3014 | C23H25F2N7O | 1332727-40-8 | Details |
| Naloxone benzoylhydrazone；NalBzoH | C26H27N3O4 | 119630-94-3 | Details |
| Monomethyl fumarate | C5H6O4 | 2756-87-8 | Details |
| MTH1-IN-2 | C24H27N3O5S | 901044-91-5 | Details |
| Mofegiline hydrochloride；MDL72974A | C11H13F2N.ClH | 120635-25-8 | Details |
| Naminterol | C19H26N2O3 | 93047-40-6 | Details |
| N-Methylmoranoline；MOR 14;N-Methyl-1-deoxynojirimycin;N-Methylmoranolin | C7H15NO4 | 69567-10-8 | Details |
| Butenafine hydrochloride | C23H27N.ClH | 101827-46-7 | Details |
| N3PT；N3-pyridyl thiamine | C13H19Cl2N3OS | 13860-66-7 | Details |
| N-Desethyl Oxybutynin-d5 hydrochloride；N-Desethyl Oxybutynin D5 hydrochloride | C20H28ClNO3 | 1173018-49-9 | Details |
| Morinidazole | C11H18N4O4 | 92478-27-8 | Details |
| MPP dihydrochloride (289726-02-9 Free base) | C29H32ClN3O3 | 911295-24-4 | Details |
| Morinidazole (R enantiomer)；R-Morinidazole | C11H18N4O4 | 898230-59-6 | Details |
| N-Me-L-Ala-maytansinol | C32H44ClN3O9 | 77668-69-0 | Details |
| MYCMI-6 | C20H19N7O | 681282-09-7 | Details |
| MSI-1701 | C37H72N4O5S | 390808-64-7 | Details |
| MtbHU-IN-1 | C44H36N4O12S2 | 59736-84-4 | Details |
| MS31 | C20H27N3O2 | 2366264-12-0 | Details |
| MR-L2 | C19H16Cl3FN4O | 2374703-19-0 | Details |
| Monacolin J | C19H28O4 | 79952-42-4 | Details |
| N-Acetyl-Calicheamicin | C57H76IN3O22S4 | 108212-76-6 | Details |
| MN58b | C32H40BrN4+ | 203192-01-2 | Details |
| MS402 | C20H19ClN2O3 | 1672684-68-2 | Details |
| ETA antagonist 1 | C20H25N3O3S | 161801-60-1 | Details |
| N-piperidine Ibrutinib hydrochloride | C22H23ClN6O | 2231747-18-3 | Details |
| Mutated EGFR-IN-2 | C29H35FN8O3 | 2050906-97-1 | Details |
| Diethylstilbestrol | C18H20O2 | 56-53-1 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | ||||